4//SEC Filing
Wilfong Diane E. 4
Accession 0001127602-22-027390
CIK 0000882095other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 3:15 PM ET
Size
8.3 KB
Accession
0001127602-22-027390
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2022-12-10+318→ 28,651 total - Exercise/Conversion
Restricted Stock Unit
2022-12-10−318→ 12,924 total→ Common Stock (318 underlying) - Tax Payment
Common Stock
2022-12-10$87.97/sh−149$13,108→ 28,502 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001374988
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 3:15 PM ET
- Size
- 8.3 KB